Related Experiment Video
Updated: Jun 13, 2026

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
Published on: December 9, 2010
On-demand engineering of bimodal nanoimaging agents for monitoring inflammation using quality-by-design
Riddhi Vichare1, Sanjida Ahmed Srishti1, Jelena M Janjic1
1Graduate School of Pharmaceutical Sciences, School of Pharmacy, Duquesne University, Pittsburgh, PA 15282, USA.
Abstract:
Inflammation is a complex immune response to injuries, infections, or tissue damage. Incomplete or dysregulated inflammation resolution accelerates disease progression and impairs functional recovery following trauma-induced injuries. Current clinical methods to monitor inflammation rely on quantifying soluble biomarkers, performing biopsies, or using non-specific nuclear imaging to detect downstream inflammation consequences. These techniques lack sensitivity for early detection and provide limited spatiotemporal information. This necessitates the development of a scalable, non-invasive nanoimaging agent capable of monitoring inflammation using clinically available imaging modalities to improve patient prognosis. Given macrophages are the key immune cells recruited at early stages and activated across different inflammatory pathologies, they function as a cellular-level readout that informs the severity of inflammation. In this work, we demonstrate the application of the quality by design (QbD) framework to develop a bimodal imaging nanoemulsion engineered for preferential size-dependent uptake by macrophages and that can be imaged using a near-infrared fluorescence optical imager and a 19F magnetic resonance imaging system. We integrated face-centered central composite design-based response surface methodology (FCCD-RSM) with desirability function-based optimization to simultaneously achieve multiple critical quality attributes (CQAs) with competing goals. Thus, providing a quantitative framework to anticipate trade-offs in CQAs if factor settings are fine-tuned according to the imaging needs. Furthermore, the presented formulation strategy extended the functional utility of indocyanine green (ICG) beyond short-term imaging procedures (< 24 h) toward multi-day inflammation monitoring using a single low dose. Overall, the study focuses on QbD application for developing a scalable nanoimaging agent and its application for imaging inflammation.
More Related Videos
06:46Non-invasive In Vivo Fluorescence Optical Imaging of Inflammatory MMP Activity Using an Activatable Fluorescent Imaging Agent
Published on: May 8, 2017
12:09A Novel High-resolution In vivo Imaging Technique to Study the Dynamic Response of Intracranial Structures to Tumor Growth and Therapeutics
Published on: June 16, 2013